Veeral Desai - Sep 14, 2021 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Chief Strategy & Dev. Officer
Signature
/s/ Lyn Amor Macaraeg, as Attorney-in-Fact
Stock symbol
AGL
Transactions as of
Sep 14, 2021
Transactions value $
-$3,385,608
Form type
4
Date filed
9/15/2021, 05:18 PM
Next filing
Mar 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Options Exercise $121K +121K +46.19% $1.00* 383K Sep 14, 2021 Direct F1
transaction AGL Common Stock Sale -$3.51M -121K -31.6% $28.98 262K Sep 14, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Options Exercise $0 -121K -10.08% $0.00 1.08M Sep 14, 2021 Common Stock 121K $1.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units.
F2 These options were granted on April 27, 2017, and fully vested on April 24, 2021.